U.S. Orders $690 Million in Swine-Flu Vaccine from Novartis Corporation, $71 Million from GlaxoSmithKline

Bookmark and Share

bizjournals.com -- The federal government is committing more than $800 million to buy more of the two key ingredients to make the H1N1 swine flu vaccine, according to the Department of Health and Human Services.
MORE ON THIS TOPIC